Louise Hiller
- Oncology top 2%
- Clinical Psychology top 1%
- Social Psychology top 1%
- Molecular Biology top 10%
- General Health Professions top 1%
- Co-authors
- Sarah Stewart‐BrownScott WeichStephen JosephRuth TennantStephen PlattJenny SeckerJane ParkinsonJanet Dunn
- Topics
- Breast Cancer Treatment Studies (35 papers)Cancer Treatment and Pharmacology (20 papers)HER2/EGFR in Cancer Research (18 papers)
- Partner nations
- United KingdomItalyCanada
In The Last Decade
Louise Hiller
77 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Oncology 1.5k
- Clinical Psychology 1.4k
- Social Psychology 1.2k
- Molecular Biology 965
- General Health Professions 826
Countries citing papers authored by Louise Hiller
This map shows the geographic impact of Louise Hiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Hiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Hiller more than expected).
Fields of papers citing papers by Louise Hiller
This network shows the impact of papers produced by Louise Hiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Hiller. The network helps show where Louise Hiller may publish in the future.
Co-authorship network of co-authors of Louise Hiller
This figure shows the co-authorship network connecting the top 25 collaborators of Louise Hiller. A scholar is included among the top collaborators of Louise Hiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Hiller. Louise Hiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 14 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 31 | |
| 10 | 82 | |
| 11 | 13 | |
| 12 | 22 | |
| 13 | 24 | |
| 14 | 19 | |
| 15 | Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer. | 1 |
| 16 | 57 | |
| 17 | 34 | |
| 18 | 31 | |
| 19 | 29 | |
| 20 | 52 |
About Louise Hiller
Louise Hiller is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 86 papers that have together received 6.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (35 papers), Cancer Treatment and Pharmacology (20 papers) and HER2/EGFR in Cancer Research (18 papers). The work is most often cited by research in Applied Psychology (431 citations), Clinical Psychology (1.4k citations) and Health (497 citations). Louise Hiller has collaborated with scholars based in United Kingdom, Italy and Canada. Frequent co-authors include Sarah Stewart‐Brown, Scott Weich, Stephen Joseph, Ruth Tennant, Stephen Platt, Jenny Secker, Jane Parkinson, Janet Dunn, Helena Earl and Tim Crook. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.